Brief: Xvivo Q1 EBIT SEK 31.9 Million
Apr 24 (Reuters) - Xvivo Q1 net income SEK 36.3 million. Q1 EPS SEK 1.15 Q1 sales SEK 241 million vs. IBES estimate SEK 238.2 million
Recent news on Xvivo Perfusion AB
See all newsSweden's XVIVO Q3 revenue beat expectations on thoracic sales
Brief: Xvivo Q3 EBIT SEK 28 Million
Brief: Xvivo Receives CE Certificates For Heart Preservation Technology
Brief: XVIVO Gets FDA Approval For Additional Patient Enrollment
Sweden's XVIVO Q2 sales beat estimates, helped by thoracic segment strength